Welcome to our dedicated page for ICON PLC SEC filings (Ticker: ICLR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for ICON plc (NASDAQ: ICLR), a Dublin, Ireland‑based clinical research organisation operating in the research and development in biotechnology industry. As a foreign private issuer, ICON files an annual report on Form 20‑F and furnishes current information on Form 6‑K.
ICON’s Form 6‑K submissions include press releases and other information made public in its home market or to shareholders. Recent 6‑K filings incorporate quarterly financial results, unaudited interim financial statements, updates on financial guidance, details of vaccine study developments, conference call schedules, participation in investor and healthcare conferences, and announcements such as CEO transitions and annual general meeting outcomes.
The company’s financial statements and related disclosures, referenced in its filings, present information on revenue, costs and expenses, income from operations, net income, cash flows and balance sheet items. They also describe elements of ICON’s capital structure, including bank credit lines, loan facilities and senior secured notes, as well as goodwill and intangible assets such as customer relationships, trade names, technology‑based assets and order or production backlog.
Through this filings page, users can review ICON’s regulatory history, including how it reports non‑GAAP measures like adjusted EBITDA, adjusted net income and adjusted diluted earnings per share, and the items excluded from those metrics. Filings are sourced in real time from the SEC’s EDGAR system, and AI‑powered tools on Stock Titan can help summarise lengthy documents, highlight key sections and make complex accounting and disclosure topics easier to understand for investors and researchers following ICON plc.
ICON (Nasdaq:ICLR) filed a routine Form 6-K that simply furnishes Exhibit 99.1 titled “ICON plc Schedules Second Quarter 2025 Earnings Conference Call.” The notice contains no financial statements, guidance, or operational updates. It also confirms the company continues to file annual reports on Form 20-F. The document was signed by Chief Financial Officer Nigel Clerkin on 23 June 2025.
ICON plc (Nasdaq: ICLR) has submitted a routine Form 6-K dated 18 June 2025 to the U.S. Securities and Exchange Commission. The filing confirms that the company continues to report under Form 20-F requirements for foreign private issuers and is signed by Chief Financial Officer Nigel Clerkin.
The sole attachment, listed as Exhibit 99.1, contains the company’s Unaudited Interim IFRS Single Company Financial Statements. No numerical results, earnings data, or transaction details are provided in the cover document itself. As such, the submission appears to be an administrative update intended to place the interim financial statements on the public record.